from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0582/vapC26

LFCtreatmentdescriptionclass of inhibitor

-0.042

Amikacinug/mL Amikacintranslation

0.376

Cap5-10ug/mL Capreomycintranslation

1.934

Rox10-50 ug/mL Roxithromycintranslation

0.592

SM2-5 ug/mL Streptomycintranslation

-0.362

Tet5-10 ug/mL Tetracyclinetranslation

0.434

Rif0.2-5ug/mL Rifampicintranscription

-0.514

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.374

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.451

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.520

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.543

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.298

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.723

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.216

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.428

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.324

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.722

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.998

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.453

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.264

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.664

KCN5-20 ug/mL Potassium cyaniderespiration

-0.132

NaN30.2-2 mM Sodium aziderespiration

-1.246

Nigericin50 uM Nigericinrespiration

0.173

TRC10-150 ug/mL Triclosanrespiration

-1.015

TRZ10-25 ug/mL Thioridazinerespiration

2.482

Valinomycin0.5-10 uM Valinomycinrespiration

0.477

ZnSO42 mM ZnSO4respiration

0.626

menadione6-10 ug/mL Menadionerespiration

-0.126

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.209

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.293

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.181

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.598

NRP_1Non-replicating persistence stage 1dosRassociated

-1.077

Amp0.2mg/mL AmpicillincellWall

0.170

Cephalexin20-100 ug/mL CephalexincellWall

-0.213

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.382

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.510

EMB10-20 ug/mL EthambutolcellWall

-0.083

Eta12-40 ug/mL EthionamidecellWall

0.053

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.685

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.619

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.059

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.260

BZA0.12 mg/mL BenzamidearomaticAmides

0.156

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.400

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.008

H2O24 mM hydrogen peroxideDNAdamaging

-0.057

Levo10 ug/mL LevofloxacinDNAdamaging

0.066

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.810

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.356

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.615

UVUV-irradiationDNAdamaging

-0.254

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.166

Antimycin12.5-50 ug/mL Antimycin A?

0.251

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.344

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.154

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.966

PA8240.2-2 ug/mL PA-824?

0.777

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.265

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.166

Verapamil50 uM Verapamil?

0.263

mercaptoethanol2 mM 2-Mercaptoethanol?

0.339

methoxatin10-20 ug/mL Methoxatin?